198 related articles for article (PubMed ID: 35657417)
21. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy.
Lee JH; Han YH; Kang BM; Mun CW; Lee SJ; Baik SK
J Neurol; 2013 Aug; 260(8):2094-101. PubMed ID: 23670309
[TBL] [Abstract][Full Text] [Related]
22. Cerebrospinal fluid levels of coenzyme Q10 are reduced in multiple system atrophy.
Compta Y; Giraldo DM; Muñoz E; Antonelli F; Fernández M; Bravo P; Soto M; Cámara A; Torres F; Martí MJ;
Parkinsonism Relat Disord; 2018 Jan; 46():16-23. PubMed ID: 29107645
[TBL] [Abstract][Full Text] [Related]
23. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
[TBL] [Abstract][Full Text] [Related]
24. Clinical features of autopsy-confirmed multiple system atrophy in the Mayo Clinic Florida brain bank.
Koga S; Cheshire WP; Tipton PW; Driver-Dunckley ED; Wszolek ZK; Uitti RJ; Graff-Radford NR; van Gerpen JA; Dickson DW
Parkinsonism Relat Disord; 2021 Aug; 89():155-161. PubMed ID: 34303202
[TBL] [Abstract][Full Text] [Related]
25. Clinical correlations of cerebrospinal fluid biomarkers including neuron-glia 2 and neurofilament light chain in patients with multiple system atrophy.
Tokutake T; Kasuga K; Tsukie T; Ishiguro T; Shimohata T; Onodera O; Ikeuchi T
Parkinsonism Relat Disord; 2022 Sep; 102():30-35. PubMed ID: 35933820
[TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal Fluid Levels of 5-Hydroxyindoleacetic Acid in Parkinson's Disease and Atypical Parkinsonian Syndromes.
Kaiserova M; Chudackova M; Prikrylova Vranova H; Mensikova K; Kastelikova A; Stejskal D; Kanovsky P
Neurodegener Dis; 2021; 21(1-2):30-35. PubMed ID: 34695830
[TBL] [Abstract][Full Text] [Related]
27. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
[TBL] [Abstract][Full Text] [Related]
28. Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis.
Sako W; Murakami N; Izumi Y; Kaji R
J Neurol Sci; 2015 May; 352(1-2):84-7. PubMed ID: 25868897
[TBL] [Abstract][Full Text] [Related]
29. Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.
van Rumund A; Aerts MB; Esselink RAJ; Meijer FJA; Verbeek MM; Bloem BR
BMC Neurol; 2018 May; 18(1):69. PubMed ID: 29764386
[TBL] [Abstract][Full Text] [Related]
30. Midbrain and pons MRI shape analysis and its clinical and CSF correlates in degenerative parkinsonisms: a pilot study.
Painous C; Pascual-Diaz S; Muñoz-Moreno E; Sánchez V; Pariente JC; Prats-Galino A; Soto M; Fernández M; Pérez-Soriano A; Camara A; Muñoz E; Valldeoriola F; Caballol N; Pont-Sunyer C; Martin N; Basora M; Tio M; Rios J; Martí MJ; Bargalló N; Compta Y
Eur Radiol; 2023 Jul; 33(7):4540-4551. PubMed ID: 36773046
[TBL] [Abstract][Full Text] [Related]
31. [Recent neuropathology of parkinsonian syndromes].
Duyckaerts C; Verny M; Hauw JJ
Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S11-8. PubMed ID: 12773883
[TBL] [Abstract][Full Text] [Related]
32. Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.
Ge J; Wu J; Peng S; Wu P; Wang J; Zhang H; Guan Y; Eidelberg D; Zuo C; Ma Y
Hum Brain Mapp; 2018 Jul; 39(7):2842-2858. PubMed ID: 29536636
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian Disorders.
Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Kremser C; Wildauer M; Schocke M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
J Parkinsons Dis; 2019; 9(4):681-691. PubMed ID: 31450511
[TBL] [Abstract][Full Text] [Related]
34. FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models.
Vidal-Martinez G; Segura-Ulate I; Yang B; Diaz-Pacheco V; Barragan JA; De-Leon Esquivel J; Chaparro SA; Vargas-Medrano J; Perez RG
Exp Neurol; 2020 Mar; 325():113120. PubMed ID: 31751571
[TBL] [Abstract][Full Text] [Related]
35. Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.
Carlos AF; Sekiya H; Koga S; Pham NTT; Ali F; Botha H; Clark HM; Coon EA; Lowe V; Ahlskog JE; Trejo-Lopez JA; Dickson DW; Whitwell JL; Josephs KA
Parkinsonism Relat Disord; 2022 Aug; 101():9-14. PubMed ID: 35752126
[TBL] [Abstract][Full Text] [Related]
36. Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders.
Constantinescu R; Zetterberg H; Holmberg B; Rosengren L
Parkinsonism Relat Disord; 2009 Mar; 15(3):205-12. PubMed ID: 18562238
[TBL] [Abstract][Full Text] [Related]
37. Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning.
Zhao Y; Wu P; Wu J; Brendel M; Lu J; Ge J; Tang C; Hong J; Xu Q; Liu F; Sun Y; Ju Z; Lin H; Guan Y; Bassetti C; Schwaiger M; Huang SC; Rominger A; Wang J; Zuo C; Shi K
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2798-2811. PubMed ID: 35588012
[TBL] [Abstract][Full Text] [Related]
38. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Bukhatwa S; Zeng BY; Rose S; Jenner P
Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
[TBL] [Abstract][Full Text] [Related]
39. Role of complement activation and disruption of the blood-brain barrier in the pathogenesis of multiple system atrophy.
Shibata M; Makioka K; Nakamura T; Kasahara H; Yamazaki T; Takatama M; Okamoto K; Ikeda Y
Neurosci Lett; 2024 Feb; 822():137642. PubMed ID: 38228218
[TBL] [Abstract][Full Text] [Related]
40. Extrastriatal
Nicastro N; Fleury V; Broc N; Burkhard PR; Garibotto V
Parkinsonism Relat Disord; 2020 Sep; 78():38-43. PubMed ID: 32698058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
